Paul E. Carlson

2.8k total citations · 2 hit papers
50 papers, 2.0k citations indexed

About

Paul E. Carlson is a scholar working on Infectious Diseases, Molecular Biology and Genetics. According to data from OpenAlex, Paul E. Carlson has authored 50 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 20 papers in Molecular Biology and 13 papers in Genetics. Recurrent topics in Paul E. Carlson's work include Clostridium difficile and Clostridium perfringens research (19 papers), Bacillus and Francisella bacterial research (12 papers) and Bacterial Genetics and Biotechnology (10 papers). Paul E. Carlson is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (19 papers), Bacillus and Francisella bacterial research (12 papers) and Bacterial Genetics and Biotechnology (10 papers). Paul E. Carlson collaborates with scholars based in United States, Canada and France. Paul E. Carlson's co-authors include Vincent B. Young, Casey M. Theriot, Gary B. Huffnagle, Jun Z. Li, Mark J. Koenigsknecht, Bo Li, Gabrielle E. Hatton, Philip C. Hanna, Gerard J. Nau and David M. Aronoff and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Paul E. Carlson

48 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection

2014 708 citations Casey M. Theriot, Mark J. Koenigsknecht et al. Nature Communications profile →
Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model

2024 46 citations Julia D. Berkson, Alyxandria M. Schubert et al. Nature Communications profile →

Peers

Countries citing papers authored by Paul E. Carlson

Since Specialization

Citations

This map shows the geographic impact of Paul E. Carlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Carlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Carlson more than expected).

Fields of papers citing papers by Paul E. Carlson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Carlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Carlson. The network helps show where Paul E. Carlson may publish in the future.

Co-authorship network of co-authors of Paul E. Carlson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Carlson. A scholar is included among the top collaborators of Paul E. Carlson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Carlson. Paul E. Carlson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model breakdown → 2024 ·Nature Communications ·Julia D. Berkson, (unknown), (unknown), Alyxandria M. Schubert, (unknown), Michael P. Coryell, (unknown), Yamei Gao, Jessica L. Hastie, (unknown), (unknown), (unknown), Paul E. Carlson	46
2	Standards for fecal microbiota transplant: Tools and therapeutic advances 2024 ·Biologicals ·Ilia Belotserkovsky, Lisa M. Stabryla, (unknown), Jessica R. Allegretti, Benjamin J. Callahan, Paul E. Carlson, Phillip J. Daschner, Maryam Goudarzi, Cyril Guyard, Scott A. Jackson, Krishna Rao, Stephanie L. Servetas, Harry Sokol, Jennifer A. Wargo, (unknown)	7
3	Nanobodies as potential tools for microbiological testing of live biotherapeutic products 2024 ·AMB Express ·(unknown), (unknown), (unknown), (unknown), Michael P. Coryell, Adovi Akue, Mark KuKuruga, Paul E. Carlson, Sheila M. Dreher‐Lesnick, Scott Stibitz	2
4	Evaluating Cefoperazone-Induced Gut Metabolic Functional Changes in MR1-Deficient Mice 2022 ·Metabolites ·Jinchun Sun, Zhijun Cao, (unknown), Paul E. Carlson, Michael P. Coryell, Huizhong Chen, Richard D. Beger	1
5	Microbiome for Mars: surveying microbiome connections to healthcare with implications for long-duration human spaceflight, virtual workshop, July 13, 2020 2021 ·Microbiome ·(unknown), Dorit Donoviel, (unknown), Paul E. Carlson, Stephanie J. Culler, Amrita K. Cheema, Rima Kaddurah‐Daouk, D. F. Kelly, (unknown), Rob Knight, Rosa Krajmalnik‐Brown, Stephen L. Mayo, Sarkis K. Mazmanian, Emeran A. Mayer, Joseph F. Petrosino, Keith Garrison	12
6	A method for detection of SARS-CoV-2 RNA in healthy human stool: a validation study 2021 ·The Lancet Microbe ·Michael P. Coryell, (unknown), (unknown), Pallavi P. Murugkar, Jason Rippe, David B. Williams, Taylor Heald‐Sargent, L. Nelson Sanchez‐Pinto, (unknown), Jessica L. Hastie, (unknown), Christopher Z. Lien, Tony T. Wang, William J. Muller, Michael A. Fischbach, Paul E. Carlson	20
7	Bile Acid Profile and its Changes in Response to Cefoperazone Treatment in MR1 Deficient Mice 2020 ·Metabolites ·Jinchun Sun, Zhijun Cao, (unknown), Paul E. Carlson, Michael P. Coryell, Huizhong Chen, Richard D. Beger	7
8	Regulatory Considerations for Fecal Microbiota Transplantation Products 2020 ·Cell Host & Microbe ·Paul E. Carlson	62
9	Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci 2019 ·Infection and Immunity ·Anushila Chatterjee, Cydney N. Johnson, (unknown), Karthik Hullahalli, Sara W. McBride, Alyxandria M. Schubert, Kelli L. Palmer, Paul E. Carlson, Breck A. Duerkop	90
10	Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection 2019 ·PLoS ONE ·(unknown), (unknown), (unknown), Jessica L. Hastie, Nicole Giordano, (unknown), (unknown), Alyxandria M. Schubert, (unknown), (unknown), Jinchun Sun, Richard D. Beger, Vahan Simonyan, Siobhán C. Cowley, Paul E. Carlson	21
11	Variation in germination of Clostridium difficile clinical isolates correlates to disease severity 2015 ·Anaerobe ·Paul E. Carlson, Alyssa M. Kaiser, (unknown), (unknown), Vincent B. Young, David M. Aronoff, Philip C. Hanna	39
12	Clostridium difficile-induced colitis in mice is independent of leukotrienes 2014 ·Anaerobe ·Bruno Caetano Trindade, Casey M. Theriot, Jhansi L. Leslie, Paul E. Carlson, Ingrid L. Bergin, Marc Peters‐Golden, Vincent B. Young, David M. Aronoff	8
13	Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection breakdown → 2014 ·Nature Communications ·Casey M. Theriot, Mark J. Koenigsknecht, Paul E. Carlson, Gabrielle E. Hatton, (unknown), Bo Li, Gary B. Huffnagle, Jun Z. Li, Vincent B. Young	708
14	Multiple ABC transporters are involved in the acquisition of petrobactin in Bacillus anthracis 2012 ·Molecular Microbiology ·(unknown), Brian K. Janes, (unknown), Paul E. Carlson, Philip C. Hanna	16
15	A Francisella tularensis Live Vaccine Strain That Improves Stimulation of Antigen-Presenting Cells Does Not Enhance Vaccine Efficacy 2012 ·PLoS ONE ·(unknown), Dawn M. O’Dee, Joseph Horzempa, Paul E. Carlson, Brian C. Russo, (unknown), (unknown), Gerard J. Nau	11
16	Cefoperazone-treated mice as an experimental platform to assess differential virulence ofClostridium difficilestrains 2011 ·Gut Microbes ·Casey M. Theriot, Charles C. Koumpouras, Paul E. Carlson, Ingrid L. Bergin, David M. Aronoff, Vincent B. Young	143
17	Genetic analysis of petrobactin transport in Bacillus anthracis 2010 ·Molecular Microbiology ·Paul E. Carlson, (unknown), Brian K. Janes, (unknown), Tyler D. Nusca, Erica C. Anderson, (unknown), David H. Sherman, Philip C. Hanna	23
18	Transcriptional Profiling of Bacillus anthracis Sterne (34F2) during Iron Starvation 2009 ·PLoS ONE ·Paul E. Carlson, (unknown), Brian K. Janes, Erica C. Anderson, Philip C. Hanna	40
19	Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis 2008 ·BMC Microbiology ·Joseph Horzempa, Paul E. Carlson, Dawn M. O’Dee, Robert M. Q. Shanks, Gerard J. Nau	66
20	UPDATING AND BROADENING THE USE OF SINGLE SUBJECT DESIGNS IN READING 1985 ·Reading Psychology ·Paul E. Carlson	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact